Nearly half of the cases (48%) had an APL-like phenotype represented by CD34(−)/HLA-DR(−)/MPO(str+), which could predict the presence of TET2 or IDH1/2 mutations, a result in line with our findings. Here, CD34 is linked to acute promyelocytic leukemia.